Por favor, use este identificador para citar o enlazar a este item:
http://hdl.handle.net/10261/141966
COMPARTIR / EXPORTAR:
SHARE CORE BASE | |
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE | |
Título: | GSE4, a small dyskerin- and GSE24.2-related peptide, induces telomerase activity, cell proliferation and reduces DNA damage, oxidative stress and cell senescence in dyskerin mutant cells |
Autor: | Iarriccio, Laura; Manguan-García, Cristina CSIC ORCID; Pintado-Berninches, Laura CSIC ORCID ; Mancheño, Jose M. CSIC ORCID; Molina, A.; Perona Abellón, Rosario CSIC ORCID; Sastre, Leandro CSIC ORCID | Fecha de publicación: | 2015 | Editor: | Public Library of Science | Citación: | PLoS ONE 10 (2015) | Resumen: | Dyskeratosis congenita is an inherited disease caused by mutations in genes coding for telomeric components. It was previously reported that expression of a dyskerin-derived peptide, GSE24.2, increases telomerase activity, regulates gene expression and decreases DNA damage and oxidative stress in dyskeratosis congenita patient cells. The biological activity of short peptides derived from GSE24.2 was tested and one of them, GSE4, that probed to be active, was further characterized in this article. Expression of this eleven amino acids long peptide increased telomerase activity and reduced DNA damage, oxidative stress and cell senescence in dyskerin-mutated cells. GSE4 expression also activated c-myc and TERT promoters and increase of c-myc, TERT and TERC expression. The level of biological activity of GSE4 was similar to that obtained by GSE24.2 expression. Incorporation of a dyskerin nuclear localization signal to GSE24.2 did not change its activity on promoter regulation and DNA damage protection. However, incorporation of a signal that increases the rate of nucleolar localization impaired GSE24.2 activity. Incorporation of the dyskerin nuclear localization signal to GSE4 did not alter its biological activity. Mutation of the Aspartic Acid residue that is conserved in the pseudouridine synthase domain present in GSE4 did not impair its activity, except for the repression of c-myc promoter activity and the decrease of c-myc, TERT and TERC gene expression in dyskerin-mutated cells. These results indicated that GSE4 could be of great therapeutic interest for treatment of dyskeratosis congenita patients. | Versión del editor: | https://doi.org/10.1371/journal.pone.0142980 | URI: | http://hdl.handle.net/10261/141966 | DOI: | 10.1371/journal.pone.0142980 | Identificadores: | doi: 10.1371/journal.pone.0142980 issn: 1932-6203 |
Aparece en las colecciones: | (IIBM) Artículos (IQF) Artículos |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
journal.pone.0142980.PDF | 4,65 MB | Adobe PDF | Visualizar/Abrir |
CORE Recommender
PubMed Central
Citations
8
checked on 18-abr-2024
SCOPUSTM
Citations
13
checked on 11-abr-2024
WEB OF SCIENCETM
Citations
14
checked on 26-feb-2024
Page view(s)
315
checked on 19-abr-2024
Download(s)
231
checked on 19-abr-2024
Google ScholarTM
Check
Altmetric
Altmetric
Artículos relacionados:
NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.